Why the study?
Can prenatal two-dimensional echocardiography detect familial hypertrophic cardiomyopathy in at-risk fetuses?
Can prenatal two-dimensional echocardiography detect familial hypertrophic cardiomyopathy in at-risk fetuses?
Two-dimensional echocardiography is a useful tool for the prenatal screening and diagnosis of familial hypertrophic cardiomyopathy.
Hypothesis-generating for prenatal HCM detection in at-risk fetuses; leaves open validation before any screening role.
Hypertrophic cardiomyopathy usually manifests clinically in the second or third decade of life. Two dimensional echocardiography is a reliable indicator of the presence of the disease. This technique is of use in the screening of fetuses at risk for familial cardiomyopathy. This report describes the prenatal echocardiographic detection of hypertrophic cardiomyopathy in the fetus of a mother with hypertrophic cardiomyopathy localized to the apical region of the left ventricle.
No takes yet. Share an insight, caveat, or question.
Stewart et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: